The Early Changes in Thyroid-Stimulating Immunoglobulin Bioassay over Anti-Thyroid Drug Treatment Could Predict Prognosis of Graves’ Disease

The Early Changes in Thyroid-Stimulating Immunoglobulin Bioassay over Anti-Thyroid Drug Treatment Could Predict Prognosis of Graves’ Disease

Background To determine whether baseline thyroid-stimulating immunoglobulin (TSI) bioassay or its early response upon treatment with an anti-thyroid drug (ATD) can predict prognosis of Graves’ disease (GD) in real-world practice. Methods This retrospective study enrolled GD patients who had previous...

Full description

Bibliographic Details
Main Authors: Jin Yu, Han-Sang Baek, Chaiho Jeong, Kwanhoon Jo, Jeongmin Lee, Jeonghoon Ha, Min Hee Kim, Jungmin Lee, Dong-Jun Lim
Format: Article
Language:English
Published: Korean Endocrine Society 2023-06-01
Series:Endocrinology and Metabolism
Subjects:
graves disease
hyperthyroidism
immunoglobulins, thyroid-stimulating
thyrotropin-binding inhibitory immunoglobulin
recurrence
antithyroid agents
Online Access:http://www.e-enm.org/upload/pdf/enm-2023-1664.pdf

Internet

http://www.e-enm.org/upload/pdf/enm-2023-1664.pdf

Similar Items